The clinical chemistry analyzers market size is valued at $1.63 billion in 2022. Clinical chemistry analyzers are used to perform tests on blood, serum, plasma, or urine samples to determine the concentration of analytes such as cholesterol, electrolytes, glucose, etc. It includes the segments semi-automated clinical chemistry analyzers and automated clinical chemistry analyzers.

   For more insights on the clinical chemistry analyzers market forecast, download a free report sample

The market for automated and integrated clinical chemistry analyzers is increasing due to the progressive automation of laboratories. Technological advancements have led to high-throughput, fully automated machines that enable laboratories to operate with a vastly improved efficiency, perform a broad spectrum of assays on a single system, reduce and eliminate errors and potentially dangerous manual testing procedures, increase productivity, reduced testing time, increase sample handling and compensate for ongoing staff shortages.

Additionally, the integrated clinical chemistry and immunochemistry analyzers allow immunoassay-based testing, which greatly increases the spectrum of tests that can be performed on a single system as well as reduces the time required for quality checks and maintenance of these analyzers. Finally, the automated and integrated analyzers come in different sample workloads and volumes (low, medium, and high) to suit the requirements of the hospital and reference labs, further contributing to increasing demand and market growth.